Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Igm Biosciences Inc (IGMS)

Igm Biosciences Inc (IGMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 580,666
  • Shares Outstanding, K 59,464
  • Annual Sales, $ 2,130 K
  • Annual Income, $ -246,420 K
  • EBIT $ -235 M
  • EBITDA $ -236 M
  • 60-Month Beta 0.20
  • Price/Sales 266.33
  • Price/Cash Flow N/A
  • Price/Book 7.18

Options Overview Details

View History
  • Implied Volatility 86.05% ( -27.27%)
  • Historical Volatility 107.59%
  • IV Percentile 6%
  • IV Rank 25.37%
  • IV High 194.08% on 08/28/24
  • IV Low 49.32% on 08/20/24
  • Put/Call Vol Ratio 11.50
  • Today's Volume 50
  • Volume Avg (30-Day) 58
  • Put/Call OI Ratio 0.67
  • Today's Open Interest 1,864
  • Open Int (30-Day) 1,844

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.74
  • Number of Estimates 8
  • High Estimate -0.48
  • Low Estimate -0.93
  • Prior Year -1.01
  • Growth Rate Est. (year over year) +26.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.58 +3.61%
on 11/18/24
20.35 -56.31%
on 10/22/24
-6.78 (-43.27%)
since 10/21/24
3-Month
8.58 +3.61%
on 11/18/24
22.50 -60.49%
on 09/17/24
-1.97 (-18.14%)
since 08/21/24
52-Week
4.72 +88.35%
on 11/28/23
22.50 -60.49%
on 09/17/24
+3.19 (+55.96%)
since 11/21/23

Most Recent Stories

More News
Snowflake Stock Jumps Over 21% In Premarket Following Beat-and-Raise Q3: Retail Brace For ‘Parabolic’ Run

Snowflake CEO Sridhar Ramaswamy said, “Our obsessive drive to produce product cohesion and ease of use has built Snowflake into the easiest and most cost effective enterprise data platform.”

SNOW : 171.35 (+32.71%)
IGMS : 8.89 (-8.96%)
IWL : 145.43 (+0.41%)
IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update

IGMS : 8.89 (-8.96%)
IGM Biosciences to Present at Three Upcoming Investor Conferences

IGMS : 8.89 (-8.96%)
Stock Index Futures Mixed Ahead of U.S. JOLTs Report and Fed Speak, Nike Earnings on Tap

December S&P 500 E-Mini futures (ESZ24) are down -0.13%, and December Nasdaq 100 E-Mini futures (NQZ24) are up +0.06% this morning as investors awaited the latest reading on U.S. job openings, comments...

CVS : 57.10 (+0.48%)
AAPL : 228.52 (-0.21%)
MKC : 77.95 (+1.06%)
IGMS : 8.89 (-8.96%)
F : 10.80 (+0.65%)
NQZ24 : 20,797.25 (-0.15%)
MU : 102.76 (+4.46%)
HPQ : 37.91 (+3.35%)
NKE : 75.10 (+2.37%)
1COV.D.DX : 57.200 (-0.24%)
PAYX : 144.09 (+1.59%)
UPS : 131.37 (-0.55%)
Change in Medivir's Board of Directors

/PRNewswire/ -- Medivir AB (Nasdaq: MVIR) and (Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of...

IGMS : 8.89 (-8.96%)
Fostrox + Lenvima continues to show promising tumor control in HCC, all patients have now dosed at least two treatment cycles

/PRNewswire/ -- Medivir AB (Nasdaq:MVIR) (Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high...

IGMS : 8.89 (-8.96%)
Medivir to present at the Pareto Securities Healthcare Conference

/PRNewswire/ -- Medivir AB (Nasdaq: MVIR) (Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high...

IGMS : 8.89 (-8.96%)
Medivir's Partner Tango Therapeutics received FDA clearance to start the TNG348 phase 1/2 clinical study

/PRNewswire/ -- Medivir AB (NASDAQ Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet...

IGMS : 8.89 (-8.96%)
Medivir presents data on additive activity of fostrox in combination with Lenvima or sorafenib in non-clinical tumor models at ILCA

/PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancers with high unmet medical...

IGMS : 8.89 (-8.96%)
Medivir reports promising interim data, including a first complete response in phase 1b/2a HCC study with fostrox in combination with Lenvima

/PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet...

IGMS : 8.89 (-8.96%)

Business Summary

IGM Biosciences Inc. is a biotechnology company. It engages in the research and development of engineered Immunoglobulin M antibodies for the treatment of cancer patients. The company's lead product candidate is IGM-2323, a bispecific T cell engaging IgM, which are in clinical stage. IGM Biosciences...

See More

Key Turning Points

3rd Resistance Point 10.72
2nd Resistance Point 10.27
1st Resistance Point 9.58
Last Price 8.89
1st Support Level 8.44
2nd Support Level 7.99
3rd Support Level 7.30

See More

52-Week High 22.50
Fibonacci 61.8% 15.71
Fibonacci 50% 13.61
Fibonacci 38.2% 11.51
Last Price 8.89
52-Week Low 4.72

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar